Correlation Between Unicycive Therapeutics and Bioatla
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Bioatla, you can compare the effects of market volatilities on Unicycive Therapeutics and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Bioatla.
Diversification Opportunities for Unicycive Therapeutics and Bioatla
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Unicycive and Bioatla is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Bioatla go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Bioatla
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.95 times more return on investment than Bioatla. However, Unicycive Therapeutics is 1.05 times less risky than Bioatla. It trades about 0.23 of its potential returns per unit of risk. Bioatla is currently generating about 0.0 per unit of risk. If you would invest 38.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 42.00 from holding Unicycive Therapeutics or generate 110.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Bioatla
Performance |
| Timeline |
| Unicycive Therapeutics |
| Bioatla |
Unicycive Therapeutics and Bioatla Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Bioatla
The main advantage of trading using opposite Unicycive Therapeutics and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Bioatla vs. Pmv Pharmaceuticals | Bioatla vs. C4 Therapeutics | Bioatla vs. Nautilus Biotechnology | Bioatla vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |